Amitriptyline for neuropathic pain and fibromyalgia in adults (Q24202439)

5

0 references

Dominic Aldington

3

0 references

Robert Andrew Moore

1

object named as

R Andrew Moore

0 references

author name string

Peter Cole

Cochrane Database of Systematic Reviews

4

0 references

publication date

12 December 2012

0 references

published in

0 references

cites work

Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Comparative study of clinical efficacy with amitriptyline, pregabalin, and amitriptyline plus pregabalin combination in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Clomipramine and Amitriptyline in the Treatment of Severe Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

The effect of guided imagery and amitriptyline on daily fibromyalgia pain: a prospective, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Low dose amitriptyline in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Dose-response for analgesic effect of amitriptyline in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Depression masquerading as diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Low dose amitriptyline in chronic pain: the gain is modest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Topical capsaicin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Prevalence and comorbidity of chronic pain in the German general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

Trazodone for deafferentation pain. Comparison with amitriptyline.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

A controlled study of amitriptyline in the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

The analgesic effect of amitriptyline on chronic facial pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable, 'psychogenic' pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

Developing a database of published reports of randomised clinical trials in pain research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB2

7 January 2021